| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/22/2004 | CA2512512A1 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | CA2511820A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection |
| 07/22/2004 | CA2511816A1 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | CA2511535A1 P53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions |
| 07/22/2004 | CA2511513A1 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | CA2511315A1 Wound healing method and kits |
| 07/22/2004 | CA2510903A1 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 07/21/2004 | EP1439230A2 Human transmembrane protein TMP-2 gene |
| 07/21/2004 | EP1439229A2 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 07/21/2004 | EP1439199A1 Medical polymers and use thereof |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438413A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/21/2004 | EP1438412A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 07/21/2004 | EP1438410A2 Promoters to control cell differentiation |
| 07/21/2004 | EP1438407A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438404A2 Inhibition of specific histone deacetylase isoforms |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438399A2 Paramyxoviruses as gene transfer vectors to lung cells |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438060A2 Prevention and treatment of restenosis by local administration of drug |
| 07/21/2004 | EP1437938A2 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins |
| 07/21/2004 | EP1268833B1 Modified nodavirus rna for gene delivery |
| 07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514737A Method of treatment of vascular regeneration |
| 07/21/2004 | CN1513559A Method capable of renforving gene gun inoculation DNA Vaccine inducel cell immune response |
| 07/21/2004 | CN1158387C Chimeric gene encoding antigenic determinants of four proteins of L.INFANTUM |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764852 Internal ribosome entry site, vector containing same and uses thereof |
| 07/20/2004 | US6764845 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764675 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/20/2004 | CA2196610C Flow through electroporation apparatus and method |
| 07/20/2004 | CA2175368C Proliferation antagonistic inhibitor of mesenchymal cells |
| 07/15/2004 | WO2004058940A2 Sirna-mediated gene silencing |
| 07/15/2004 | WO2004058939A2 TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs |
| 07/15/2004 | WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | WO2004058323A2 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 07/15/2004 | WO2004058308A1 An efficient non-viral gene/drug delivery system |
| 07/15/2004 | WO2004058306A1 Tumor supression through bicistronic co-expression of p53 and p14arf |
| 07/15/2004 | WO2004058293A1 Methods of diagnosing, preventing, and treating early onset of pulmonary hypertension |
| 07/15/2004 | WO2004058290A1 Inhibition of hiv replication by expression of late domain peptides in target cells |
| 07/15/2004 | WO2004058178A2 Uses of mammalian cytokine; related reagents |
| 07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
| 07/15/2004 | WO2004058159A2 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | WO2004046320A3 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 07/15/2004 | WO2004042027A3 Allele-specific rna interference |
| 07/15/2004 | WO2004033634A3 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 07/15/2004 | WO2004031357A3 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 07/15/2004 | WO2004030630A3 Focal calcium channel modulation |
| 07/15/2004 | WO2004028442A3 Use of excipients to increase dna uptake by swine muscle cells |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2004010927A3 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003106647A3 Antisense modulation of junctional adhesion molecule 3 expression |
| 07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003089612A3 IMPROVED rAAV VECTORS |
| 07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003018751A3 Apparatus and method for electroporation of biological samples |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 07/15/2004 | US20040139489 Method for generating cloned animals using chromosome shuffling |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138165 Nucleic acids; drug or gene product; stabilization; gene therapy; purification using free radical scavenger |
| 07/15/2004 | US20040138163 Anticancer agents; antiproliferative agents |
| 07/15/2004 | US20040138156 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138154 Solid surface for biomolecule delivery and high-throughput assay |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138134 Method and composition for treatment of skeletal dysplasias |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138127 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 07/15/2004 | US20040138115 DNA sequence comprising endorphin codes for proopiomelanocortin genes (POMC), deleted of the coding regions for adrenocorticotropic hormone (ACTH) and beta-melanocyte stimulating hormone ( beta -MSH); anlagesics; gene therapy |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138111 Composition and method to alter lean body mass and bone properties in a subject |
| 07/15/2004 | US20040137626 AAV ITR-mediated modulation |
| 07/15/2004 | US20040137625 Compositions and methods for drug delivery using amphiphile binding molecules |
| 07/15/2004 | US20040137623 Delivery of oligonucleotide compounds into osteoclasts and modulation of osteoclast differentiation |
| 07/15/2004 | US20040137622 Modular transfection systems |
| 07/15/2004 | US20040137621 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |